These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11162046)

  • 21. Critical issues in site-specific targeting of solid tumours: the carrier, the tumour barriers and the bioavailable drug.
    Hamad I; Moghimi SM
    Expert Opin Drug Deliv; 2008 Feb; 5(2):205-19. PubMed ID: 18248319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
    Marcucci F; Lefoulon F
    Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiment and clinical application of targeting treatment with adriamycin magnetic albumin microspheres in human gastric carcinoma].
    Tao K; Chen D; Wang G; Bai Z; Lu X; Tian Y; Wu Z; Hu F; Nie X
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):205-7. PubMed ID: 11829819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-guided drug delivery systems.
    Stacy DR; Lu B; Hallahan DE
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):283-8. PubMed ID: 15056058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
    Gindy ME; Prud'homme RK
    Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Targeting to tumor site by the conjugate of antitumor drug with synthetic polymer].
    Hirano T; Ohashi S; Todoroki T; Inaba M; Tsukagoshi S
    Nihon Rinsho; 1989 Jun; 47(6):1412-6. PubMed ID: 2770002
    [No Abstract]   [Full Text] [Related]  

  • 28. [Polymeric drug carriers activated by ultrasounds energy].
    Kik K; Lwow F; Szmigiero L
    Polim Med; 2007; 37(3):59-65. PubMed ID: 18251205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anticancer drug dosing--pharmacogenomic biomarkers or body surface area?].
    Lehne G; Bjørheim J; Saeter G
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1040-4. PubMed ID: 17457389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OncoGel (ReGel/paclitaxel)--clinical applications for a novel paclitaxel delivery system.
    Elstad NL; Fowers KD
    Adv Drug Deliv Rev; 2009 Aug; 61(10):785-94. PubMed ID: 19422870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
    Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
    Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microfluidic assisted synthesis of multi-functional polycaprolactone microcapsules: incorporation of CdTe quantum dots, Fe3O4 superparamagnetic nanoparticles and tamoxifen anticancer drugs.
    Yang CH; Huang KS; Lin YS; Lu K; Tzeng CC; Wang EC; Lin CH; Hsu WY; Chang JY
    Lab Chip; 2009 Apr; 9(7):961-5. PubMed ID: 19294308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An in vitro study of magnetic particle targeting in small blood vessels.
    Udrea LE; Strachan NJ; Bădescu V; Rotariu O
    Phys Med Biol; 2006 Oct; 51(19):4869-81. PubMed ID: 16985276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomedical applications of distally controlled magnetic nanoparticles.
    Corchero JL; Villaverde A
    Trends Biotechnol; 2009 Aug; 27(8):468-76. PubMed ID: 19564057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Targeting of magnetically responsive drug carriers to cancer].
    Morimoto Y; Natsume H
    Nihon Rinsho; 1989 Jun; 47(6):1432-6. PubMed ID: 2770004
    [No Abstract]   [Full Text] [Related]  

  • 37. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Not only anticancer drugs but also enzymes can be encapsulated in either micelle or other carrier for the treatment of cancer.
    Tan Q; Zhang J; Zhang L
    Med Hypotheses; 2010 Feb; 74(2):396-7. PubMed ID: 19762160
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.